These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31146604)

  • 1. Obstetric and pediatric growth charts for the detection of fetal growth restriction and neonatal adverse outcomes in preterm newborns before 34 weeks of gestation.
    Fernandez-Rodriguez B; de Alba C; Villalain C; Pallás CR; Galindo A; Herraiz I
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1112-1119. PubMed ID: 31146604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstetric and pediatric growth charts for the detection of late-onset fetal growth restriction and neonatal adverse outcomes.
    Fernandez-Rodriguez B; de Alba C; Galindo A; Recio D; Villalain C; Pallas CR; Herraiz I
    J Perinat Med; 2021 Feb; 49(2):216-224. PubMed ID: 33027055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the optimal growth charts for use in a preterm population: An Australian state-wide retrospective cohort study.
    Pritchard NL; Hiscock RJ; Lockie E; Permezel M; McGauren MFG; Kennedy AL; Green B; Walker SP; Lindquist AC
    PLoS Med; 2019 Oct; 16(10):e1002923. PubMed ID: 31584941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small for gestational age at preterm birth identifies adverse neonatal outcomes more reliably than antenatal suspicion of fetal growth restriction.
    Alda MG; Holberton J; MacDonald TM; Charlton JK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279017. PubMed ID: 37981759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal and fetal growth charts to identify preterm infants <30 weeks gestation at risk of adverse outcomes.
    Boghossian NS; Geraci M; Edwards EM; Horbar JD
    Am J Obstet Gynecol; 2018 Aug; 219(2):195.e1-195.e14. PubMed ID: 29750954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome.
    Sovio U; Smith GCS
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S738-S744. PubMed ID: 29199029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study.
    Lio A; Rosati P; Pastorino R; Cota F; Tana M; Tirone C; Aurilia C; Ricci C; Gambacorta A; Paladini A; Mappa I; Buongiorno S; Zannoni GF; Romagnoli C; Vento G
    BMJ Open; 2017 Jul; 7(7):e015232. PubMed ID: 28729313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and neonatal outcomes of preterm infants born before 32 weeks of gestation according to antenatal vs postnatal assessments of restricted growth.
    Monier I; Ancel PY; Ego A; Jarreau PH; Lebeaux C; Kaminski M; Goffinet F; Zeitlin J;
    Am J Obstet Gynecol; 2017 May; 216(5):516.e1-516.e10. PubMed ID: 28188770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study.
    Monier I; Blondel B; Ego A; Kaminiski M; Goffinet F; Zeitlin J
    BJOG; 2015 Mar; 122(4):518-27. PubMed ID: 25346493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customized versus Population Growth Standards for Morbidity and Mortality Risk Stratification Using Ultrasonographic Fetal Growth Assessment at 22 to 29 Weeks' Gestation.
    Blue NR; Grobman WA; Larkin JC; Scifres CM; Simhan HN; Chung JH; Saade GR; Haas DM; Wapner R; Reddy UM; Mercer B; Parry SI; Silver RM
    Am J Perinatol; 2021 Aug; 38(S 01):e46-e56. PubMed ID: 32198743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing INTERGROWTH-21st Century and Hadlock growth standards to predict small for gestational age and short-term neonatal outcomes.
    Nwabuobi C; Odibo L; Camisasca-Lopina H; Leavitt K; Tuuli M; Odibo AO
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1906-1912. PubMed ID: 30614334
    [No Abstract]   [Full Text] [Related]  

  • 13. INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality and morbidity.
    Anderson NH; Sadler LC; McKinlay CJD; McCowan LME
    Am J Obstet Gynecol; 2016 Apr; 214(4):509.e1-509.e7. PubMed ID: 26546850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcomes following early fetal growth restriction: a subgroup analysis of the EVERREST study.
    Lingam I; Okell J; Maksym K; Spencer R; Peebles D; Buquis G; Ambler G; Morsing E; Ley D; Singer D; Tenorio V; Dyer J; Ginsberg Y; Weissbach T; Huertas-Ceballos A; Marlow N; David A;
    Arch Dis Child Fetal Neonatal Ed; 2023 Nov; 108(6):599-606. PubMed ID: 37185272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of INTERGROWTH-21 and Fenton growth standards to assess size at birth and extrauterine growth in very preterm infants.
    Tuzun F; Yucesoy E; Baysal B; Kumral A; Duman N; Ozkan H
    J Matern Fetal Neonatal Med; 2018 Sep; 31(17):2252-2257. PubMed ID: 28587527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal growth restriction: underdiagnosed condition with non-optimal screening.
    Atallah A; Butin M; Moret S; Claris O; Gaucherand P; Doret-Dion M
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8237-8244. PubMed ID: 34420493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Customized GROW vs INTERGROWTH-21
    Fay E; Hugh O; Francis A; Katz R; Sitcov K; Souter V; Gardosi J
    Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100545. PubMed ID: 34875415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the INTERGROWTH-21
    Miranda J; Maestre N; Paternina-Caicedo Á; Parra-Saavedra M; Caradeux J; Sepulveda-Martinez Á; Pelaez-Chomba M; Torres A; Parra-Cordero M; Diaz-Corvillón P; Gallo DM; Santacruz D; Rodriguez N; Sarmiento A; Benavides JA; Girado S; Rojas-Suarez JA; Gratacós E; Figueras F
    Int J Gynaecol Obstet; 2023 Jun; 161(3):1083-1091. PubMed ID: 36606760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort.
    El Ayoubi M; Jarreau PH; Van Reempts P; Cuttini M; Kaminski M; Zeitlin J;
    J Matern Fetal Neonatal Med; 2016; 29(4):596-601. PubMed ID: 25747950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.